Maria Angelidis-Smith Sells 33,554 Shares of Lemonade, Inc. (NYSE:LMND) Stock

Lemonade, Inc. (NYSE:LMND) Director Maria Angelidis-Smith sold 33,554 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $30.33, for a total transaction of $1,017,692.82. Following the completion of the sale, the director now directly owns 40,916 shares of the company’s stock, valued at $1,240,982.28. The trade was a 45.06 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Maria Angelidis-Smith also recently made the following trade(s):

• On Wednesday, November 13th, Maria Angelidis-Smith acquired 15,042 shares of Lemonade stock. The shares were bought at an average cost of $33.23 per share, with a total value of $499,845.66.
• On Friday, November 8th, Maria Angelidis-Smith bought 18,512 shares of Lemonade stock. The stock was bought at an average price of $27.42 per share, for a total transaction of $507,599.04.

Lemonade Price Performance

LMND opened at $34.31 on Tuesday. Lemonade, Inc. has a 1-year low of $14.03 and a 1-year high of $35.17. The stock has a market cap of $2.45 billion, a P/E ratio of -11.29 and a beta of 1.68. The stock’s 50 day simple moving average is $20.69 and its 200 day simple moving average is $18.72.

Lemonade (NYSE:LMND) last posted its earnings results on Wednesday, October 30th. The company reported ($0.95) earnings per share for the quarter, beating the consensus estimate of ($1.02) by $0.07. The company had revenue of $136.60 million for the quarter, compared to analyst estimates of $129.10 million. Lemonade had a negative return on equity of 32.85% and a negative net margin of 43.51%. Lemonade’s revenue was up 19.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.88) earnings per share. Research analysts expect that Lemonade, Inc. will post -3.05 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Jefferies Financial Group lowered their price objective on shares of Lemonade from $15.00 to $14.00 and set an “underperform” rating on the stock in a research report on Wednesday, October 9th. JMP Securities reiterated a “market outperform” rating and set a $40.00 price target on shares of Lemonade in a research note on Tuesday, October 15th. Keefe, Bruyette & Woods downgraded shares of Lemonade from a “market perform” rating to an “underperform” rating and raised their price objective for the company from $18.00 to $21.00 in a research report on Thursday, November 7th. Piper Sandler lifted their price objective on Lemonade from $18.00 to $25.00 and gave the company a “neutral” rating in a report on Friday, November 1st. Finally, Morgan Stanley increased their target price on Lemonade from $15.00 to $23.00 and gave the stock an “underweight” rating in a research note on Friday. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Lemonade has an average rating of “Hold” and a consensus price target of $23.33.

Hedge Funds Weigh In On Lemonade

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LMND. Axiom Advisory LLC grew its position in shares of Lemonade by 1.6% in the third quarter. Axiom Advisory LLC now owns 54,400 shares of the company’s stock valued at $897,000 after purchasing an additional 850 shares during the last quarter. Blue Trust Inc. increased its position in Lemonade by 220.0% during the third quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock worth $45,000 after buying an additional 1,879 shares in the last quarter. Van ECK Associates Corp raised its holdings in shares of Lemonade by 12.1% in the second quarter. Van ECK Associates Corp now owns 17,774 shares of the company’s stock worth $293,000 after acquiring an additional 1,915 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Lemonade by 9.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 24,609 shares of the company’s stock valued at $404,000 after acquiring an additional 2,196 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Lemonade by 9.7% during the second quarter. The Manufacturers Life Insurance Company now owns 29,194 shares of the company’s stock valued at $482,000 after acquiring an additional 2,582 shares during the last quarter. Institutional investors and hedge funds own 80.30% of the company’s stock.

Lemonade Company Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.